We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

NanoString Technologies Inc (NSTG) USD0.0001

Sell:$33.76 Buy:$41.02 Change: $1.42 (3.66%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Change: $1.42 (3.66%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Change: $1.42 (3.66%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NanoString Technologies, Inc. develops, manufactures, and sells products of biological material. Its core technology includes chemistries that enable the labeling and counting of single molecules. The single-molecule chemistries enable the direct detection, identification, and quantification of individual target molecules in biological samples by attaching molecular reporters to each target molecule of interest. It uses its core technology to develop tools for scientific and clinical research. It offers two product platforms, including nCounter Analysis System, and its GeoMx Digital Spatial Profiler (GeoMx DSP) systems. The nCounter Analysis System is used to analyze the activity of genes in a single experiment and is also used by clinicians to analyze gene activity relevant for diagnostic applications. The GeoMx DSP is used to facilitate the analysis of selected regions of a biological sample to see how gene activity vary across those regions or in certain cell types.

Contact details

530 Fairview Ave N
United States
+1 (206) 3786266

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.75 billion
Shares in issue:
45.65 million
Life Sciences Tools & Services
United States
US dollar

Key personnel

  • R. Bradley Gray
    President, Chief Executive Officer, Director
  • K. Thomas Bailey
    Chief Financial Officer
  • Joseph Beechem
    Senior Vice President - Research and Development, Chief Scientific Officer
  • John Brown
    Senior Vice President - Sales and Marketing

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.